Grant: Project Grant - Priority Announcement: Global Health Research - CRPPHE
University of Toronto
$100,000.00
Strengthening Canada's Drug Supply Chain: Establishing the Canadian Drug Shortage Observatory
EF 2024-25
Résumé
In the last twenty years, drug shortages have become a major issue worldwide. Drug shortages occur when patients can't access necessary medications due to supply issues. Between 2015 and 2019, Canada faced over 2,000 drug shortages, and both the number and severity of these shortages have increased. A notable example was the 2022 children's Tylenol shortage, which highlighted significant weaknesses in our drug supply chain. In response, the Prime Minister tasked Health Canada with creating a strategy to prevent future shortages. Causes of drug shortages include manufacturing problems, shipping delays, sole-source contracts, increased demand, and difficulties in obtaining raw materials. These shortages can lead to worsening health conditions, increased hospitalizations, premature deaths, and higher healthcare costs. Our proposal builds on eight years of research into the clinical and economic impacts of drug shortages. We aim to establish a National Drug Shortage Observatory to enhance evidence that will directly inform policies to support drug supply resilience in Canada through continuous monitoring, evaluation, and collaborative efforts. The Observatory will have three overarching objectives: updating, validating, and maintaining the At-Risk Medicine List through annual updates and validation against actual drug shortage events from 2022-2025; evaluating and responding to drug supply issues using linked health databases to assess safety outcomes and policy impacts; and continuing collaboration among industry leaders through a formal platform for sharing ideas, best practices, and solutions, including hosting an annual Drug Shortage Symposium at the University of Toronto. Our national team, comprising experts in health policy, drug safety, economics, and knowledge translation, will ensure the project's success and its significant impact on mitigating drug shortages in Canada.
Programme
Project Grant - Priority Announcement: Global Health Research - CRPPHE
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
514593
Name
Tadrous Mina
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Policy & Systems Management Research
Projecttitle
Strengthening Canada's Drug Supply Chain: Establishing the Canadian Drug Shortage Observatory
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Global Health Research - CRPPHE
Keyworddelim
Drug Safety; Drug Shortages; Health Outcomes; Health Policy; Pharmaceutical; Supply Chain
Abstract
In the last twenty years, drug shortages have become a major issue worldwide. Drug shortages occur when patients can't access necessary medications due to supply issues. Between 2015 and 2019, Canada faced over 2,000 drug shortages, and both the number and severity of these shortages have increased. A notable example was the 2022 children's Tylenol shortage, which highlighted significant weaknesses in our drug supply chain. In response, the Prime Minister tasked Health Canada with creating a strategy to prevent future shortages. Causes of drug shortages include manufacturing problems, shipping delays, sole-source contracts, increased demand, and difficulties in obtaining raw materials. These shortages can lead to worsening health conditions, increased hospitalizations, premature deaths, and higher healthcare costs. Our proposal builds on eight years of research into the clinical and economic impacts of drug shortages. We aim to establish a National Drug Shortage Observatory to enhance evidence that will directly inform policies to support drug supply resilience in Canada through continuous monitoring, evaluation, and collaborative efforts. The Observatory will have three overarching objectives: updating, validating, and maintaining the At-Risk Medicine List through annual updates and validation against actual drug shortage events from 2022-2025; evaluating and responding to drug supply issues using linked health databases to assess safety outcomes and policy impacts; and continuing collaboration among industry leaders through a formal platform for sharing ideas, best practices, and solutions, including hosting an annual Drug Shortage Symposium at the University of Toronto. Our national team, comprising experts in health policy, drug safety, economics, and knowledge translation, will ensure the project's success and its significant impact on mitigating drug shortages in Canada.
Competitiondate
202409
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tadrous, Mina; Ahmed, Saad; Beall, Reed; Fahim, Christine; Gomes, Tara
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~